Early detection of ovarian cancer
作者： M. G. Teneriello , R. C. Park
关键词:
摘要: Ovarian cancer meets the criteria of a disease for which screening can be justified. The is most often diagnosed in advanced stages, when chances long-term survival are poor. Yet effective treatment exists early-stage disease, such that early detection increase survival. However, ovarian with high specificity necessary this low-prevalence has proven to challenge. This article reviews issues cancer, including pathology, statistical considerations, diagnostic modalities, and results major clinical studies undertaken.
sci-hub.se 参考文章(59)
Daniel L. Clarke-Pearson, Cheryl A. Szpak, Verda J. Hunter, William T. Creasman, Leslie Massad, Epithelial ovarian tumors of low malignant potential. Obstetrics & Gynecology. ,vol. 78, pp. 1027- 1032 ,(1991)
B R Benacerraf, B Bromley, H Goodman, Comparison between sonographic morphology and Doppler waveform for the diagnosis of ovarian malignancy. Obstetrics & Gynecology. ,vol. 83, pp. 434- 437 ,(1994)
Robert E. Scully, Robert C. Bast, Robert C. Knapp, Nina Einhorn, Paul Hall, Vincent R. Zurawski, Kerstin Sjövall, Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstetrics & Gynecology. ,vol. 80, pp. 14- 18 ,(1992)
Leo B. Twiggs, Linda F. Carson, Jeffrey M. Fowler, Andrew K. Saltzman, Ellen M. Hartenbach, Jonathan Carter, Flow characteristics in benign and malignant gynecologic tumors using transvaginal color flow doppler Obstetrics & Gynecology. ,vol. 83, pp. 125- 130 ,(1994)
M. Muto, R. S. Berkowitz, E. E. Sheets, R. C. Knapp, H. M. Goodman, Chi-Ho Mok, K. Oike, C. C. Lau, Sai-Wah Tsao, Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors. Anticancer Research. ,vol. 11, pp. 1975- 1982 ,(1991)
Hugh R. K. Barber, Prophylaxis in ovarian cancer. Cancer. ,vol. 71, pp. 1529- 1533 ,(1993) , 10.1002/CNCR.2820710419
I E Timor-Tritsch, C Westhoff, W B Warren, A M Sassone, A Artner, Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstetrics & Gynecology. ,vol. 78, pp. 70- 76 ,(1991)
A. Berchuck, D. L. Clarke-Pearson, Billie-Jo M. Kerns, Andrew M. Davidoff, Robert C. Bast Jr., Jeffrey R. Marks, Jeffrey C. Pence, R. K. Dodge, James Dirk Iglehart, P. A. Humphrey, Overexpression and Mutation of p53 in Epithelial Ovarian Cancer Cancer Research. ,vol. 51, pp. 2979- 2984 ,(1991)
M. J. Birrer, M. G. Teneriello, R. C. Park, M. Henry, J. D. Nash, R. I. Linnoila, M. Ebina, p53 and Ki-ras Gene Mutations in Epithelial Ovarian Neoplasms Cancer Research. ,vol. 53, pp. 3103- 3108 ,(1993)
Ian Jacobs, Robert C. Bast, The CA 125 tumour-associated antigen: a review of the literature Human Reproduction. ,vol. 4, pp. 1- 12 ,(1989) , 10.1093/OXFORDJOURNALS.HUMREP.A136832